Archive for 2017

New patent expiration for Bristol-myers Squibb drug EVOTAZ

Annual Drug Patent Expirations for EVOTAZ Evotaz is a drug marketed by Bristol-myers Squibb and is included in one NDA. It is available from one supplier. There are three patents…
The post New patent expiration for Bristol-myers Squibb drug EVOTA…


New patent expiration for Novo Nordisk drug NOVOLOG PENFILL

Annual Drug Patent Expirations for NOVOLOG+PENFILL Novolog Penfill is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from three suppliers. There is…
The post New patent expiration for Novo Nordisk drug NOVOLOG PEN…


New patent expiration for Novo Nordisk drug NOVOLOG MIX 50/50

Annual Drug Patent Expirations for NOVOLOG+MIX+50%2F50 Novolog Mix 50/50 is a drug marketed by Novo Nordisk Inc and is included in one NDA. There is one patent protecting this drug.…
The post New patent expiration for Novo Nordisk drug NOVOLOG MI…


New patent expiration for Novo Nordisk drug NOVOLOG INNOLET

Annual Drug Patent Expirations for NOVOLOG+INNOLET Novolog Innolet is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from three suppliers. There are…
The post New patent expiration for Novo Nordisk drug NOVOLOG IN…


New patent expiration for Novo Nordisk drug NOVOLOG FLEXTOUCH

Annual Drug Patent Expirations for NOVOLOG+FLEXTOUCH Novolog Flextouch is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from three suppliers. There are…
The post New patent expiration for Novo Nordisk drug NOVOLO…


New patent expiration for Novo Nordisk drug NOVOLOG FLEXPEN

Annual Drug Patent Expirations for NOVOLOG+FLEXPEN Novolog Flexpen is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from three suppliers. There are…
The post New patent expiration for Novo Nordisk drug NOVOLOG FL…


New patent expiration for Novo Nordisk drug NOVOLOG

Annual Drug Patent Expirations for NOVOLOG Novolog is a drug marketed by Novo Nordisk Inc and is included in three NDAs. It is available from three suppliers. There are sixteen…
The post New patent expiration for Novo Nordisk drug NOVOLOG appeare…


New patent expiration for Bristol Myers drug REYATAZ

Annual Drug Patent Expirations for REYATAZ Reyataz is a drug marketed by Bristol Myers Squibb and is included in two NDAs. It is available from six suppliers. There are two…
The post New patent expiration for Bristol Myers drug REYATAZ appeared f…


Do NOT follow this link or you will be banned from the site!
Get email updates

Get new actionable insights and updates from BiotechBlog